Home > Formulary : Adult > Recent Decisions > 2021 >
Decisions 27th April 2021
At the meeting on the 27th April the following decisions were agreed
New Drug Requests
Approved
Methoxyflurane (inhaled) (Penthrox®) (TLS Red)
- Adjunct for moderate to severe pain for women undergoing ambulatory gynaecology procedures
Evorel® Conti patch
- (estradiol & norethisterone)
Lenzetto® transdermal spray
- (estradiol)
- Reserved for patients where transdermal treatment is indicated (e.g. oral HRT contra-indicated, not tolerated or ineffective) and where transdermal patches are inappropriate.
Shared Care Protocols/TLS changes
TLS changes:
- Mycophenolate for autoimmune hepatitis and inflammatory bowel disease changed from TLS Red to TLS Amber 3 months to be incorporated into existing shared care protocol for rheumatological conditions. TLS change pending updated shared care protocol approval at JFG.
Other Formulary Decisions:
- A system wide review of melatonin is to be completed. No individual melatonin new drug requests will be considered until full melatonin review is complete.